IGF2BP3 was originally identified in pancreatic cancer [28], and it has since been revealed to be strongly identified in many cancer tissues, including colon cancer, hepatic cancer, lung cancer, and cervical cancer [29]. This evidence concerns the gene IGF2BP3 and cervical cancer.